Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects of either sex Group A type 2 diabetes drug naive HbA1c 7 to 9 percentage Group B Type 2 diabetes on metformin monotherapy HbA1c 7 to 9 percentage Group C prediabetes drug naive HbA1c 5.7 to 6.4 non hypertensive or controlled hypertensive agree for written informed consent
Exclusion criteria
Exclusion criteria: type 1 diabetes mellitus diabetic complications, hypertension Hb less than 10 pregnant and lactating women LFT RFT TSH and lipid profile under abnormal limits psychiatric illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| changes in HbA1c glycated serum protein albuminTimepoint: Baseline and at 1 3 6 12 18 and 24 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in cystinallated truncated and di or tri oxydised albumin changes in HOMA 2 IR and HOMA 2 B Changes in FBS PPBS lipid profile LFT HSCRP Sr Creat e GFRand urine albumin creatinine ratio Change in DSQ and ASQ scoresTimepoint: baseline and at 1 3 6 12 18 and 24 months | — |
Countries
India
Contacts
Samatvam Science and Research for Human Welfare Trust